Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study
Titel:
Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study
Auteur:
Vlachopoulos, C. Massia, D. Kochiadakis, G. Kolovou, G. Patsilinakos, S. Bridges, I. Sibartie, M. Dhalwani, N.N. Liberopoulos, E. Ray, K.K.